PHARIXIA

This brand name is authorized in Canada, Hong Kong

Active ingredients

The drug PHARIXIA contains one active pharmaceutical ingredient (API):

1 Benzydamine UNII K2GI407R4Q - BENZYDAMINE HYDROCHLORIDE

Benzydamine exerts an anti-inflammatory and analgesic action by stabilising the cellular membrane and inhibiting prostaglandin synthesis. Read about Benzydamine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PHARIXIA Mouthwash	Health Products and Food Branch (CA)	MPI, CA: SPM

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A01AD02	Benzydamine	A Alimentary tract and metabolism → A01 Stomatological preparations → A01A Stomatological preparations → A01AD Other agents for local oral treatment
Discover more medicines within A01AD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02229777, 02494434
Country: HK	Department of Health Drug Office	Identifier(s): 64739